BioRem Financial Statements From 2010 to 2025

BRM Stock  CAD 2.42  0.05  2.02%   
BioRem financial statements provide useful quarterly and yearly information to potential BioRem Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on BioRem financial statements helps investors assess BioRem's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting BioRem's valuation are summarized below:
Gross Profit
6.2 M
Profit Margin
0.1135
Market Capitalization
46.5 M
Enterprise Value Revenue
0.8802
Revenue
30.9 M
There are over one hundred nineteen available fundamental signals for BioRem Inc, which can be analyzed over time and compared to other ratios. All traders should should validate BioRem's prevailing fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable. Market Cap is likely to drop to about 9.6 M in 2025. Enterprise Value is likely to drop to about 9 M in 2025

BioRem Total Revenue

18.46 Million

Check BioRem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRem's main balance sheet or income statement drivers, such as Depreciation And Amortization of 281.4 K, Total Revenue of 18.5 M or Gross Profit of 5.5 M, as well as many indicators such as Price To Sales Ratio of 0.68, Dividend Yield of 0.0 or PTB Ratio of 2.89. BioRem financial statements analysis is a perfect complement when working with BioRem Valuation or Volatility modules.
  
This module can also supplement various BioRem Technical models . Check out the analysis of BioRem Correlation against competitors.

BioRem Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets15.1 M27.7 M15.2 M
Slightly volatile
Short and Long Term Debt Total2.9 M4.8 M2.7 M
Pretty Stable
Other Current LiabilitiesM2.5 M2.2 M
Slightly volatile
Total Current Liabilities16.8 M16 M9.6 M
Slightly volatile
Property Plant And Equipment Net2.4 M2.3 M837.7 K
Slightly volatile
Cash3.1 M2.6 M3.1 M
Slightly volatile
Non Current Assets Total1.9 M3.1 M1.8 M
Slightly volatile
Cash And Short Term Investments2.7 M2.6 MM
Slightly volatile
Net Receivables18.2 M17.3 M9.2 M
Slightly volatile
Common Stock Shares Outstanding22.9 M19.7 M25.6 M
Slightly volatile
Liabilities And Stockholders Equity15.1 M27.7 M15.2 M
Slightly volatile
Inventory764.8 KM749.3 K
Slightly volatile
Other Current Assets1.1 M2.1 M998.5 K
Slightly volatile
Other Stockholder EquityM2.1 M5.4 M
Slightly volatile
Total Liabilities21 M20 M11.2 M
Slightly volatile
Total Current Assets12.4 M23.7 M13.4 M
Slightly volatile
Short Term Debt1.2 M650.8 K1.3 M
Slightly volatile
Common Stock4.3 M4.5 M10.9 M
Slightly volatile
Accounts Payable7.4 M7.1 M3.6 M
Slightly volatile
Current Deferred Revenue5.2 MM2.4 M
Slightly volatile
Good Will1.1 M1.3 M1.4 M
Slightly volatile
Intangible Assets24.7 K26 K244.2 K
Slightly volatile
Non Currrent Assets Other3.8 M3.6 M1.7 M
Slightly volatile
Short and Long Term Debt468.1 K492.7 K2.1 M
Slightly volatile
Property Plant Equipment1.4 M1.3 M640.6 K
Slightly volatile
Long Term Debt2.8 M2.8 M2.6 M
Slightly volatile
Short Term Investments573.8 K607.2 K531 K
Slightly volatile
Net Invested Capital8.1 M8.7 M8.7 M
Slightly volatile
Net Working Capital5.8 MMM
Slightly volatile
Other AssetsM1.7 M2.5 M
Slightly volatile
Capital Stock8.9 M4.5 M13.6 M
Slightly volatile
Property Plant And Equipment Gross5.3 M6.7 M4.2 M
Slightly volatile
Capital Lease Obligations869.8 K1.4 M856.5 K
Pretty Stable

BioRem Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization281.4 K344.4 K275.3 K
Very volatile
Total Revenue18.5 M28.9 M19.8 M
Slightly volatile
Gross Profit5.5 MM5.5 M
Slightly volatile
Other Operating Expenses18 M25.4 M18.8 M
Slightly volatile
Research Development26 K27.4 K304.9 K
Slightly volatile
Cost Of Revenue13.6 M21 M14.3 M
Slightly volatile
Total Operating ExpensesM4.4 M4.5 M
Slightly volatile
Selling General Administrative2.4 M1.9 M2.3 M
Pretty Stable
Selling And Marketing Expenses1.9 M2.1 M2.1 M
Pretty Stable
Reconciled Depreciation271.2 K440.1 K167.7 K
Slightly volatile

BioRem Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation67 K114.9 K57 K
Slightly volatile
Begin Period Cash Flow2.9 M4.3 MM
Slightly volatile
Depreciation281.4 K344.4 K275.3 K
Very volatile
Capital Expenditures667.6 K635.8 K205.4 K
Slightly volatile
End Period Cash FlowM2.6 MM
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.680.720.5029
Slightly volatile
Days Sales Outstanding239252159
Slightly volatile
Average Payables5.1 M4.9 M3.3 M
Slightly volatile
Stock Based Compensation To Revenue0.00530.00580.0041
Pretty Stable
Capex To Depreciation1.371.30.8489
Slightly volatile
EV To Sales0.760.80.5166
Slightly volatile
Inventory Turnover15.4218.1220.7574
Very volatile
Days Of Inventory On Hand24.3920.8520.1376
Pretty Stable
Payables Turnover3.62.664.5071
Very volatile
Sales General And Administrative To Revenue0.130.07430.1205
Slightly volatile
Average Inventory503.3 K805.4 K753.7 K
Slightly volatile
Research And Ddevelopement To Revenue0.00130.00140.0204
Slightly volatile
Capex To Revenue0.02650.02530.0094
Slightly volatile
Cash Per Share0.240.170.1798
Pretty Stable
Days Payables Outstanding10514293.9454
Very volatile
Intangibles To Total Assets0.00410.00430.0304
Slightly volatile
Current Ratio1.621.711.5201
Slightly volatile
Receivables Turnover1.981.52.5614
Slightly volatile
Graham Number1.091.040.6376
Slightly volatile
Capex Per Share0.04260.04060.0187
Very volatile
Average Receivables5.1 M10.1 M6.9 M
Slightly volatile
Revenue Per Share2.571.852.9004
Slightly volatile
Interest Debt Per Share0.310.330.6518
Slightly volatile
Debt To Assets0.250.20.2368
Slightly volatile
Operating Cycle259272179
Slightly volatile
Days Of Payables Outstanding10514293.9454
Very volatile
Ebt Per Ebit1.261.051.0551
Pretty Stable
Long Term Debt To Capitalization0.290.310.7586
Slightly volatile
Total Debt To Capitalization0.620.440.5794
Slightly volatile
Quick Ratio1.551.631.4317
Slightly volatile
Net Income Per E B T1.140.91.7393
Slightly volatile
Cash Ratio0.180.190.3506
Pretty Stable
Cash Conversion Cycle12413095.3353
Slightly volatile
Days Of Inventory Outstanding24.3920.8520.1376
Pretty Stable
Days Of Sales Outstanding239252159
Slightly volatile
Fixed Asset Turnover10.8111.3862.5406
Pretty Stable
Debt Ratio0.250.20.2368
Slightly volatile
Price Sales Ratio0.680.720.5029
Slightly volatile
Asset Turnover1.00.941.4068
Slightly volatile
Gross Profit Margin0.340.320.2874
Very volatile

BioRem Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap9.6 M12.3 M10.5 M
Slightly volatile
Enterprise ValueM13.1 M10 M
Slightly volatile

BioRem Fundamental Market Drivers

Forward Price Earnings11.2233
Cash And Short Term Investments2.3 M

About BioRem Financial Statements

BioRem investors use historical fundamental indicators, such as BioRem's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioRem. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred RevenueM5.2 M
Total Revenue28.9 M18.5 M
Cost Of Revenue21 M13.6 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.07  0.13 
Capex To Revenue 0.03  0.03 
Revenue Per Share 1.85  2.57 
Ebit Per Revenue 0.11  0.12 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioRem Stock Analysis

When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.